Does EDARAVONE Cause Poor venous access? 17 Reports in FDA Database

Q: Does EDARAVONE cause Poor venous access?

17 reports of Poor venous access have been filed with the FDA for EDARAVONE, representing 0.5% of all EDARAVONE adverse event reports.

Q: How dangerous is Poor venous access from EDARAVONE?

Of 17 reports, 2 (11.8%) resulted in death and 3 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Poor venous access have been filed in association with EDARAVONE (edaravone). This represents 0.5% of all adverse event reports for EDARAVONE.

Reports of Poor venous access with EDARAVONE

0.5%

of all EDARAVONE reports

Deaths

Hospitalizations

How Dangerous Is Poor venous access From EDARAVONE?

Of the 17 reports, 2 (11.8%) resulted in death, 3 (17.6%) required hospitalization.

Is Poor venous access Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EDARAVONE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does EDARAVONE Cause?

Death (707) Disease progression (309) Drug ineffective (292) Amyotrophic lateral sclerosis (199) Fatigue (174) Asthenia (157) Condition aggravated (147) Muscular weakness (138) Dyspnoea (136) Gait disturbance (111)

What Other Drugs Cause Poor venous access?

VEDOLIZUMAB (1,043) INFLIXIMAB (917) INFLIXIMAB-DYYB (782) ECULIZUMAB (555) HUMAN IMMUNOGLOBULIN G (504) NATALIZUMAB (422) RITUXIMAB (299) TOCILIZUMAB (287) METHOTREXATE (257) ABATACEPT (249)

Which EDARAVONE Alternatives Have Lower Poor venous access Risk?

EDARAVONE vs EDETATE EDARAVONE vs EDOXABAN EDARAVONE vs EDOXABAN TOSILATE EDARAVONE vs EFALIZUMAB EDARAVONE vs EFANESOCTOCOG ALFA

EDARAVONE Full Profile All Poor venous access Reports All Drugs Causing Poor venous access EDARAVONE Demographics